This course explores the new advances of emerging technologies in spine surgery. It explores the current state of technology for treating spinal pathology. Topics include intraoperative imaging, navigation, robotics, next generation microscopes and surgical instruments, combinatorial technologies, augmented reality and surgical simulators.
The AANS designates this activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
After completing this educational activity, participants should be able to:
- Develop an understanding of the role of emerging technologies in improving the care of neurosurgical patients with spinal disorders.
- Identify the indications to use and the expected outcomes of utilizing navigation and emerging technologies in the treatment of spinal disorders.
- Develop a strategy to implement new technologies, providing beneficial spinal care for patients with spinal disorders.
Doniel Gabriel Drazin, MD
Joseph S. Cheng, MD, MS, FAANS
Peter Grunert, MD
J. Patrick Johnson, MD, FAANS
Neil R. Malhotra, MD, FAANS
Avelino Parajon, MD (Spain)
Ehab Shiban, MD
Nicholas Theodore, MD, FAANS
Claudius Thome, MD, IFAANS (Austria)
Michael Y. Wang, MD, FAANS
This educational activity was recorded at the 2019 AANS Annual Scientific Meeting.
The AANS controls the content and production of this CME activity and attempts to ensure the presentation of balanced, objective information. In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclose any relationship they or their co-authors have with commercial interests, which may be related to the content of their lecture.
The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere or any other relationship to a commercial interest that provides sufficient reason for disclosure.
Speakers, paper presenters/authors and staff (and the significant others of those mentioned) who have disclosed a relationship with commercial interests whose products may be relevant to their presentation are listed below.
|Avelino Parajon||AOSpine, AOFoundation, DePuySynthes, RTI,Globu, ZimmerBiomet,Spineart||Speaker's Bureau, Consultant Fees,Consultant Fees,Consultant Fees,Consultant Fees,Consultant Fees|
|Ehab Shiban||Icotec , nevro||Grants/Research SupportHonorarium|
|Nicholas Theodore||Synthes Depuy,Globus Medical, Codman & Shurtleff, Inc., Medtronic, GuidePoint Global Consulting, Penumbra, Stryker, MicroVention, W.L. Gore & Associates, Three Rivers Medical, Inc., Corindus, Inc., Amnis Therapeutics, Ltd., CereVasc, LLC, Pulsar Vascular, The Stroke Project, Inc., Cer , NREF||Consultant FeesOther Financial Support,Consultant FeesOther Financial SupportStock Shareholder ,Other Financial Support,Grants/Research Support|
|Claudius Thome||Depuy Synthes Inc.,Signus Medical Inc.,TETEC AG, Intrinsic Therapeutics Inc.,Icotec Inc., BrainLab Inc. Aesculap Inc.||Consultant FeesGrants/Research SupportHonorarium, Consultant FeesGrants/Research Support, Honorarium,Grants/Research Support,Consultant FeesGrants/Research Support,Grants/Research SupportHonorarium|
|Michael Y. Wang, MD, FAANS||Depuy Spine, Centers for Diagnostic Imaging Provider Led Entity, Variation Biotechnology Inc.,ISD,Neuro Consulting, LLC, Vallum,Medical Device Partners, Quality Medical Publishing,BrainLab Inc.||Consultant FeesOther Financial Support, Consultant Fees, Stock Shareholder,Other Financial SupportStock Shareholder,Stock Shareholder, Other Financial Support,Honorarium|
Those who have reported they do not have any relationships with commercial interests:
Joseph S. Cheng
J. Patrick Johnson
Neil R. Malhotra
Doniel Gabriel Drazin
The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care or course of management does not imply endorsement or disapproval of products.
Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients served.
The AANS designates this internet enduring material activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Term of approval is for three years, beginning from 04/6/2020 until 04/6/2023.
© 2019 American Association of Neurological Surgeons